Edition:
United States

Chugai Pharmaceutical Co Ltd (4519.T)

4519.T on Tokyo Stock Exchange

7,350JPY
10:29pm EDT
Change (% chg)

¥-110 (-1.47%)
Prev Close
¥7,460
Open
¥7,290
Day's High
¥7,400
Day's Low
¥7,290
Volume
252,500
Avg. Vol
691,318
52-wk High
¥7,900
52-wk Low
¥6,170

About

CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Domestic segment is engaged in the sale of pharmaceutical products manufactured by the Company through its nationwide appointed stores. This segment is also involved in the research, development, transportation and storage of pharmaceutical products, as... (more)

Overall

Beta: 0.83
Market Cap(Mil.): ¥4,298,388.00
Shares Outstanding(Mil.): 559.69
Dividend: 48.00
Yield (%): 1.16

Financials

  4519.T Industry Sector
P/E (TTM): 37.23 29.73 33.85
EPS (TTM): 206.31 -- --
ROI: 14.34 13.04 12.69
ROE: 14.85 14.12 17.13

BRIEF-Chugai Pharmaceutical Says Tecentriq Approved As Lung Cancer Treatment In Japan

* CHUGAI PHARMACEUTICAL - TECENTRIQ RECEIVES APPROVAL FOR ADDITIONAL INDICATION OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER FROM JAPAN'S MHLW

Aug 22 2019

BRIEF-Chugai Obtains Approval Of FoundationOne CDx Cancer Genomic Profile As A Companion Diagnostic For Rozlytrek

* CHUGAI PHARMACEUTICAL - CHUGAI OBTAINS APPROVAL OF FOUNDATIONONE CDX CANCER GENOMIC PROFILE AS A COMPANION DIAGNOSTIC FOR ROZLYTREK Source text for Eikon: Further company coverage:

Jun 27 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates